Cell Line News and Research

RSS
Natural compound found in cardamom shows promise for treating triple-negative breast cancer

Natural compound found in cardamom shows promise for treating triple-negative breast cancer

3 Apr 2022
Research demonstrates potential of local siRNA delivery as COVID antiviral therapy in the lung

Research demonstrates potential of local siRNA delivery as COVID antiviral therapy in the lung

3 Apr 2022
Study explores molecular mechanisms underlying SARS-CoV-2 infection of macrophages and the induction of pro-inflammatory cytokines

Study explores molecular mechanisms underlying SARS-CoV-2 infection of macrophages and the induction of pro-inflammatory cytokines

1 Apr 2022
Chemical in leafy greens could prevent infections by coronaviruses including SARS-CoV-2

Chemical in leafy greens could prevent infections by coronaviruses including SARS-CoV-2

30 Mar 2022
A summary of SARS-CoV-2 RNA-protein interactome studies

A summary of SARS-CoV-2 RNA-protein interactome studies

30 Mar 2022
Study analyzed several naturally-occurring amino acid variations found in the extended loop harboring the SARS-CoV-2 S1/S2 cleavage site

Study analyzed several naturally-occurring amino acid variations found in the extended loop harboring the SARS-CoV-2 S1/S2 cleavage site

30 Mar 2022
Antiviral functions of interferon regulatory factors during human coronavirus infection

Antiviral functions of interferon regulatory factors during human coronavirus infection

30 Mar 2022
Study shows that the SARS-CoV-2 envelope protein potently restricts HIV-1 infection

Study shows that the SARS-CoV-2 envelope protein potently restricts HIV-1 infection

30 Mar 2022
ProteoGenix launches new XtenCHOTM Transient CHO Expression System to improve biologics development

ProteoGenix launches new XtenCHOTM Transient CHO Expression System to improve biologics development

From ProteoGenix 30 Mar 2022
A bioinformatics approach for detecting SARS-CoV-2 co-infections

A bioinformatics approach for detecting SARS-CoV-2 co-infections

29 Mar 2022
Researchers discover new pathway for DNA transfer in tumor microenvironment

Researchers discover new pathway for DNA transfer in tumor microenvironment

25 Mar 2022
Scientists identify a promising strategy for stopping Ebola virus polymerase

Scientists identify a promising strategy for stopping Ebola virus polymerase

23 Mar 2022
Study evaluates interactions between SARS-CoV-2 proteins and viral and host RNA

Study evaluates interactions between SARS-CoV-2 proteins and viral and host RNA

22 Mar 2022
New test greatly simplifies the diagnosis of allergies

New test greatly simplifies the diagnosis of allergies

21 Mar 2022
Study shows SARS-CoV-2 infection induces global alterations of the host endomembrane system

Study shows SARS-CoV-2 infection induces global alterations of the host endomembrane system

11 Mar 2022
Effect of COVID-19 mRNA vaccine on in vitro glial cells of the brain studied by Raman spectroscopy and imaging

Effect of COVID-19 mRNA vaccine on in vitro glial cells of the brain studied by Raman spectroscopy and imaging

8 Mar 2022
Orbit Discovery and WuXi AppTec sign agreement to access peptide discovery and optimisation technologies

Orbit Discovery and WuXi AppTec sign agreement to access peptide discovery and optimisation technologies

8 Mar 2022
New, highly promising strategy to overcome a key cause of cancer deaths

New, highly promising strategy to overcome a key cause of cancer deaths

7 Mar 2022
Triple drug regimen proven effective against non-structural protein-1 of SARS-CoV-2

Triple drug regimen proven effective against non-structural protein-1 of SARS-CoV-2

2 Mar 2022
Antigenic differences between Omicron BA.1 and BA.2 SARS-CoV-2 variants

Antigenic differences between Omicron BA.1 and BA.2 SARS-CoV-2 variants

2 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback